Investigating the Plasma Lipoprotein Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans
Phase of Trial: Phase II/III
Latest Information Update: 29 Oct 2018
At a glance
- Drugs Teduglutide (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- Acronyms GLP-2 Plasma
- 19 Oct 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 19 Oct 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2019.
- 19 Oct 2018 Status changed from not yet recruiting to recruiting.